Literature DB >> 24378872

Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis.

Y Xiao1, J Zhang, X He, J Ji, G Wang.   

Abstract

AIM: A meta-analysis was performed to assess the diagnostic values of carcinoembryonic antigen (CEA) in predicting the peritoneal recurrence after curative resection of gastric cancer.
METHODS: The Medline, Embase, Web of Science, Ovid and Cochrane databases, Google Scholar and Vivisimo engines were searched to identify studies reporting on the accuracy of CEA protein or CEA mRNA in predicting the postoperative peritoneal recurrence of gastric cancer. Publication bias was demonstrated by Funnel plots and Egger test. The sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated and summary receiver operating characteristic curves were generated.
RESULTS: Seven and eight studies fulfilled the inclusion criteria for CEA protein and mRNA determination, including 635 and 849 patients, respectively. The pooled sensitivity, specificity and DOR of CEA protein for predicting the peritoneal recurrence were 0.77 (95 % CI 0.69-0.84), 0.89 (95 % CI 0.86-0.92), 29.71 (95 % CI 10.27-85.92), respectively. Similarly, the values for CEA mRNA were 0.82 (95 % CI 0.75-0.88), 0.82 (95 % CI 0.79-0.85) and 22.97 (95 % CI 10.90-48.41). Meanwhile, the sensitivity and DOR of CEA protein or mRNA were higher than those of cytology, while higher specificity was noted in cytology assay.
CONCLUSION: CEA protein and mRNA levels in peritoneal lavage show a high diagnostic accuracy and may help accurately predict the peritoneal recurrence after curative resection of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24378872     DOI: 10.1007/s11845-013-1051-6

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  45 in total

1.  Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer.

Authors:  N Abe; T Watanabe; H Toda; H Machida; K Suzuki; T Masaki; T Mori; M Sugiyama; Y Atomi; Y Nakaya
Journal:  Am J Surg       Date:  2001-04       Impact factor: 2.565

2.  Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts.

Authors:  Elaine M C To; Wing-Yee Chan; Chit Chow; Enders Kwok-Wai Ng; Sheung-Chi Sydney Chung
Journal:  Diagn Mol Pathol       Date:  2003-06

3.  Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.

Authors:  Hideaki Ueno; Kazuhiro Yoshida; Toshihiro Hirai; Fujiko Kono; Masayuki Kambe; Tetsuya Toge
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

4.  The diagnostic odds ratio: a single indicator of test performance.

Authors:  Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

5.  Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.

Authors:  Ji-Kun Li; Miao Zheng; Chuan-Wen Miao; Jian-Hai Zhang; Guang-Han Ding; Wen-Shen Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

6.  Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup.

Authors:  Yasuhiro Kodera; Hayao Nakanishi; Seiji Ito; Yoshinari Mochizuki; Norifumi Ohashi; Yoshitaka Yamamura; Michitaka Fujiwara; Masahiko Koike; Masae Tatematsu; Akimasa Nakao
Journal:  J Am Coll Surg       Date:  2005-11-18       Impact factor: 6.113

7.  Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.

Authors:  Jaw-Yuan Wang; Shiu-Ru Lin; Chien-Yu Lu; Chung-Chi Chen; Deng-Chyang Wu; Chee-Yin Chai; Fang-Ming Chen; Jan-Sing Hsieh; Tsung-Jen Huang
Journal:  Cancer Lett       Date:  2004-10-28       Impact factor: 8.679

Review 8.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  BMJ       Date:  2003-01-04

9.  Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma.

Authors:  S Noda; K Soejima; K Inokuchi
Journal:  Jpn J Surg       Date:  1980-12

10.  Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction.

Authors:  H Nakanishi; Y Kodera; A Torii; T Hirai; Y Yamamura; T Kato; T Kito; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1997-07
View more
  8 in total

Review 1.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

2.  Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis.

Authors:  Kai Deng; Hong Zhu; Mo Chen; Junchao Wu; Renwei Hu; Chengwei Tang
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

3.  Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.

Authors:  Fan Feng; Yangzi Tian; Guanghui Xu; Zhen Liu; Shushang Liu; Gaozan Zheng; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

4.  PROGNOSTIC VALUE OF CARCINOEMBRYONIC ANTIGEN LEVELS IN TRANSOPERATIVE PERITONEAL LAVAGE IN PATIENTS WITH GASTRIC CANCER.

Authors:  Letícia Biscaino Alves; Maria Teresa Tsukazan; Ana Elisa Serafim; Rolando Mendoza; Alexandre Vontobel Padoin; Plínio Carlos Baú; Luis Fernando Moreira
Journal:  Arq Bras Cir Dig       Date:  2018-06-21

5.  Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study.

Authors:  Martin Graversen; Sönke Detlefsen; Claus Fristrup; Per Pfeiffer; Michael Bau Mortensen
Journal:  Pleura Peritoneum       Date:  2018-06-12

Review 6.  Classic tumor markers in gastric cancer. Current standards and limitations.

Authors:  Călin Căinap; Viorica Nagy; Alexandra Gherman; Sanziana Cetean; Istvan Laszlo; Anne-Marie Constantin; Simona Căinap
Journal:  Clujul Med       Date:  2015-04-15

Review 7.  Risk Assessment and Preventive Treatment for Peritoneal Recurrence Following Radical Resection for Gastric Cancer.

Authors:  Lin Xiang; Shuai Jin; Peng Zheng; Ewetse Paul Maswikiti; Yang Yu; Lei Gao; Jing Zhang; Ying Zhang; Hao Chen
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

8.  Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III.

Authors:  Jingjing Li; Qi Xu; Cong Luo; Lei Chen; Jieer Ying
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.